PAI-1 level increased exponentially as the number of diagnostic criteria increased linearly as the number of diagnostic criteria increased linearly, supporting the conclusion that MetS components have a joint effect that is stronger than their additive contributions.
BACKGROUND
The menopause stage involves a significant reduction in circulating estrogen levels, resulting in notable changes to the cardiovascular, metabolic, bone, and immune systems. Monocyte chemoattractant protein-1 (MCP-1) is strongly associated with cardiovascular diseases and obesity. However, it is crucial to e...
Lourdes Basurto, Violeta Castro-Leyva, S. Vega-García et al.· Gaceta Médica de México· 0 citations
Elevated Lp(a) was independently associated with IHD across all BMI categories, without significant interaction between BMI and Lp(a), and these findings support consideration of Lp(a) assessment across the BMI spectrum.
Ezequiel Forte, M. Arrupe, Leonardo Bufi et al.· Diabetes, Metabolic Syndrome...· 0 citations
Findings support the emerging concept that Lp(a) may function as a molecular-inflammatory mediator potentially contributing to residual cardiovascular risk and highlight the importance of incorporating Lp(a) assessment into cardiometabolic risk stratification, particularly in high-risk populations.
Mohammad G. Qaddoumi, A. Albatineh, I. Alkhairi et al.· Biomedicines· 0 citations
SGLT-2 inhibitors and GLP-1 receptor agonists form an effective strategy for managing MetS in the context of T2DM and their broad effects on metabolism and well-known heart and kidney benefits make them vital parts of modern treatment for cardiometabolic conditions.
Hadeeqah Zayaan Riaz Ahamed, Sulthan Al Rashid, Rajkapoor Balasubramanian et al.· Cardiovascular & Haematologi...· 0 citations
The results do not support the use of a simple count of MetS components as an indicator of subclinical cardiovascular dysfunction related to atherosclerosis and AS, and most associations were explained by confounding variables.
M. Starzak, Grzegorz K. Jakubiak, N. Pawlas et al.· Journal of Clinical Medicine· 1 citation
Lipoprotein(a) (Lp(a)) is a significant independent cardiovascular risk factor (CVR) associated with the development of atherosclerotic cardiovascular disease (CVD), heart failure, atrial fibrillation, and increased overall and cardiovascular mortality. The aim of the study: to assess the incidence of elevated Lp(a)...
O. Timoshchenko, O. V. Tsygankova, E. Shakhtshneider et al.· Ateroscleroz· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.